PGN-EDODM1

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1NCT06667453PEPGPhase 2Recruiting2027-03Estimated
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)NCT07220603PEPGPhase 2Recruiting2029-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.